Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: Analysis by the Pharmachild Safety Adjudication Committee
- Giancane G.
- Swart J. F.
- Castagnola E.
- Groll A. H.
- Horneff G.
- Huppertz H. -I.
- Lovell D. J.
- Wolfs T.
- Herlin T.
- Dolezalova P.
- Sanner H.
- Susic G.
- Sztajnbok F.
- Maritsi D.
- Constantin T.
- Vargova V.
- Sawhney S.
- Rygg M.
- Oliveira S. K.
- Cattalini M.
- Bovis F.
- Bagnasco F.
- Pistorio A.
- Martini A.
- Wulffraat N.
- Ruperto N.
- Cuttica R.
- Garay S. M.
- Brunner J.
- Emminger W.
- Appenzeller S.
- Len C.
- Saad Magalhaes C.
- Telcharova-Mihaylovska A.
- Harjacek M.
- Jelusic M.
- Estmann A.
- Nielsen S.
- Herrera Mora C.
- Gervais E.
- Kone-Paut I.
- Quartier P.
- Foeldvari I.
- Horneff G.
- Lutz T.
- Minden K.
- Tzaribachev N.
- Trachana M.
- Tsitsami E.
- Vougiouka O.
- Orban I.
- Harel L.
- Hashkes P.
- Uziel Y.
- Cimaz R.
- Civino A.
- Consolini R.
- D'Angelo G.
- De Benedetti F.
- Filocamo G.
- Fueri E.
- Gallizzi R.
- Maggio M. C.
- Magnolia M. G.
- Miniaci A.
- Montin D.
- Olivieri A. N.
- Pastore S.
- Rigante D.
- Zulian F.
- Rumba-Rozenfelde I.
- Stanevicha V.
- Panaviene V.
- Rodriguez Lozano A. L.
- Rubio-Perez N.
- Vega Cornejo G.
- Hoppenreijs E.
- Kamphuis S.
- Flato B.
- Nordal E. B.
- Abdwani R.
- Miraval T.
- Paz Gastanaga M. E.
- Smolewska E.
- Ailioaie C.
- Cochino A. -V.
- Laday M.
- Lazar C.
- Alexeeva E.
- Chasnyk V.
- Keltsev V.
- Suwairi W. M. S.
- Vijatov-Djuric G.
- Vojinovic J.
- Arkachaisri T.
- Koskova E.
- Avcin T.
- Ally M.
- Van Rensburg C. J.
- Louw I.
- Lopez J. A.
- Boteanu A. L.
- Calvo Penades I.
- De Inocencio J.
- Mesa-Del-Castillo P.
- Moreno E.
- Remesal A.
- Hofer M.
- Gok F.
- Ozen S.
- Ramanan A.
- Pallotti C.
- Villa L.
DOIAbstract
Background: To derive a list of opportunistic infections (OI) through the analysis of the juvenile idiopathic arthritis (JIA) patients in the Pharmachild registry by an independent Safety Adjudication Committee (SAC). Methods: The SAC (3 pediatric rheumatologists and 2 pediatric infectious disease specialists) elaborated and approved by consensus a provisional list of OI for use in JIA. Through a 5 step-procedure, all the severe and serious infections, classified as per MedDRA dictionary and retrieved in the Pharmachild registry, were evaluated by the SAC by answering six questions and adjudicated with the agreement of 3/5 specialists. A final evidence-based list of OI resulted by matching the adjudicated infections with the provisional lis...
Add to ORKG